IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
news byte: Chantix users should be monitored for suicidal behavior, depressed mood and other changes in behavior
From:
Sylvia Caras <[log in to unmask]>
Reply To:
[log in to unmask]
Date:
Sat, 2 Feb 2008 17:46:43 -0800
Content-Type:
text/plain
Parts/Attachments:
text/plain (14 lines) 
Chantix users should be monitored for suicidal behavior, depressed mood 
and other changes in behavior

Chantix, an oral tablet taken up to twice daily for 12 weeks to help 
adults stop smoking, was approved in the U.S. in May 2006. Sales of the 
drug totaled $280 million during the fourth quarter, up from $68 million 
during the same time period in 2006.

http://online.wsj.com/article/SB120189673998036071.html?mod=googlenews_wsj



Powered by LSoft's LISTSERV(R) list management software

ATOM RSS1 RSS2